PT1117390E - Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais - Google Patents

Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais

Info

Publication number
PT1117390E
PT1117390E PT99954718T PT99954718T PT1117390E PT 1117390 E PT1117390 E PT 1117390E PT 99954718 T PT99954718 T PT 99954718T PT 99954718 T PT99954718 T PT 99954718T PT 1117390 E PT1117390 E PT 1117390E
Authority
PT
Portugal
Prior art keywords
animals
pharmacies
mucosa
originating
applications
Prior art date
Application number
PT99954718T
Other languages
English (en)
Inventor
Charles J Matson
Chen Yen-Lane
Daniel T Ruth
Luce R M Benes
Sophie G Burgaud
Francoise L R Horriere
Isabelle M L Seyler
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of PT1117390E publication Critical patent/PT1117390E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PT99954718T 1998-10-02 1999-10-01 Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais PT1117390E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10295698P 1998-10-02 1998-10-02

Publications (1)

Publication Number Publication Date
PT1117390E true PT1117390E (pt) 2005-01-31

Family

ID=22292601

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99954718T PT1117390E (pt) 1998-10-02 1999-10-01 Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais

Country Status (19)

Country Link
EP (1) EP1117390B1 (pt)
JP (1) JP2002526403A (pt)
KR (1) KR20010075528A (pt)
CN (1) CN1321086A (pt)
AT (1) ATE273698T1 (pt)
AU (1) AU768040B2 (pt)
BR (1) BR9915020A (pt)
CA (1) CA2345808A1 (pt)
CZ (1) CZ20011188A3 (pt)
DE (1) DE69919554T2 (pt)
ES (1) ES2228125T3 (pt)
HU (1) HUP0103543A2 (pt)
IL (1) IL142168A0 (pt)
MX (1) MXPA01003310A (pt)
NO (1) NO20011656D0 (pt)
NZ (1) NZ510771A (pt)
PL (1) PL347061A1 (pt)
PT (1) PT1117390E (pt)
WO (1) WO2000019987A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2006335640A (ja) * 2005-05-06 2006-12-14 Daicho Kikaku:Kk 動物用薬剤
RU2414193C2 (ru) * 2005-07-29 2011-03-20 Сантен Фармасьютикал Ко., Лтд. Неинвазивная система доставки лекарственного средства к ткани заднего сегмента глаза с применением твердой композиции
WO2007103511A1 (en) * 2006-03-07 2007-09-13 Oramelts International, Inc. Multi-layer medical patch with impermeable center
AU2007275581B2 (en) 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
DE202008017304U1 (de) 2008-02-29 2009-08-27 Acino Ag Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren
CA2762107A1 (en) * 2009-05-15 2010-11-18 Recro Pharma, Inc. Sublingual dexmedetomidine compositions and methods of use thereof
JP2012533557A (ja) * 2009-07-17 2012-12-27 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ 舌上ワクチン及びアプリケーター
EP2570217B1 (de) 2011-09-15 2014-11-05 Klingelnberg AG Semi-Completing Wälzschälverfahren und Vorrichtung mit entsprechendem Wälzschälwerkzeug zum Ausführen eines Semi-Completing Wälzschälverfahrens
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
EP3054930B1 (en) 2013-10-07 2020-12-02 Teikoku Pharma USA, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
TWI629061B (zh) * 2013-10-07 2018-07-11 美商帝國製藥美國股份有限公司 包含右美托嘧啶(dexmedetomidine)經皮組成物之疼痛處理用方法及組成物
CN105764494A (zh) 2013-10-07 2016-07-13 帝国制药美国公司 右旋美托咪啶经皮递送装置及其使用方法
WO2015054059A2 (en) 2013-10-07 2015-04-16 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
EP3054934B1 (en) * 2013-10-07 2024-05-22 Teikoku Pharma USA, Inc. Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
GB1455251A (en) * 1972-08-25 1976-11-10 Evode Ltd Method of sealing gaps and compositions therefor heat
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
FR2712807B1 (fr) * 1993-11-24 1996-02-23 Vetoquinol Sa Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine

Also Published As

Publication number Publication date
MXPA01003310A (es) 2003-05-15
NO20011656L (no) 2001-04-02
DE69919554D1 (de) 2004-09-23
HUP0103543A2 (hu) 2002-01-28
KR20010075528A (ko) 2001-08-09
CN1321086A (zh) 2001-11-07
PL347061A1 (en) 2002-03-11
EP1117390B1 (en) 2004-08-18
BR9915020A (pt) 2001-08-14
WO2000019987A1 (en) 2000-04-13
NO20011656D0 (no) 2001-04-02
CZ20011188A3 (cs) 2001-08-15
ATE273698T1 (de) 2004-09-15
AU768040B2 (en) 2003-11-27
DE69919554T2 (de) 2005-09-01
JP2002526403A (ja) 2002-08-20
IL142168A0 (en) 2002-03-10
CA2345808A1 (en) 2000-04-13
ES2228125T3 (es) 2005-04-01
EP1117390A1 (en) 2001-07-25
NZ510771A (en) 2003-08-29
AU1100100A (en) 2000-04-26

Similar Documents

Publication Publication Date Title
PT1117390E (pt) Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais
ATE417604T1 (de) Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
HUP0300246A2 (en) Delivery system
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
MXPA03000014A (es) Metodos para utilizar con fines beneficiosos toxina tetanica en animales.
TR199902325T2 (xx) �kame edilmi� piridinler ve bifeniller.
ES2091737T3 (es) Formulaciones farmaceuticas de fluoxetina.
HK1096857A1 (en) Medicamentously targeted local lipolysis
DE59906392D1 (de) Hyaluronatlyase als penetrationsförderer in topischen mitteln
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ATE337712T1 (de) Zusammensetzung zur intestinalen verabreichung
CY1109221T1 (el) Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
DK1082131T3 (da) Immunoregulator
TR200100637T2 (tr) Yeni doğal ürün türevleri
PT1051187E (pt) Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt)
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
MX9803610A (es) Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico.
UA31156A (uk) Спосіб лікування пневмоентеритів телят
FR2783396B1 (fr) Dispositif de diffusion lente de produits de traitement, notamment phytosanitaires
UA32111A (uk) Спосіб одержання препарату для лікування захворювань опорно-рухового апарату
ITMI981648A0 (it) Procedimento perfezionato per la produzione di combustibile da rifiuto e impianto per la realizzazione del detto procedimento
UA49889C2 (uk) Антибактеріальний препарат "бороцин"
DZ2949A1 (fr) Compositions pharmaceutiques de celecoxib, leurs procédés de préparation et procédés de traitement les utilisant.